ARGX
argenx SE
$
637.560
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
646.930
Open
637.240
VWAP
641.99
Vol
470.74K
Mkt Cap
39.02B
Low
636.100
Amount
302.21M
EV/EBITDA(TTM)
76.12
Total Shares
59.43M
EV
35.52B
EV/OCF(TTM)
--
P/S(TTM)
13.88
argenx SE, formerly arGEN X BV, is a Netherlands-based biopharmaceutical company. It is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
Show More
Get winning stock picks in minutes
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
1.08B
+83.14%
4.277
+207.26%
1.20B
+59.12%
5.320
+617.79%
1.15B
+43.87%
4.626
+81.29%
Estimates Revision
The market is revising No Change the revenue expectations for argenx SE (ARGX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 17.53%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+12.41%
In Past 3 Month
Stock Price
Go Up
+17.53%
In Past 3 Month
22 Analyst Rating
25.37% Upside
Wall Street analysts forecast ARGX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARGX is 799.30 USD with a low forecast of 699.00 USD and a high forecast of 1070 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
21 Buy
1 Hold
0 Sell
Strong Buy
25.37% Upside
Current: 637.560
Low
699.00
Averages
799.30
High
1070
25.37% Upside
Current: 637.560
Low
699.00
Averages
799.30
High
1070
Deutsche Bank
Emmanuel Papadakis
Buy
maintain
2025-08-04
Reason
Deutsche Bank
Emmanuel Papadakis
Price Target
2025-08-04
maintain
Buy
Reason
Deutsche Bank analyst Emmanuel Papadakis raised the firm's price target on Argenx to EUR 655 from EUR 550 and keeps a Buy rating on the shares.
JPMorgan
NULL -> Overweight
maintain
2025-08-04
Reason
JPMorgan
Price Target
2025-08-04
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Argenx to EUR 730 from EUR 700 and keeps an Overweight rating on the shares.
Barclays
NULL -> Overweight
maintain
2025-08-04
Reason
Barclays
Price Target
2025-08-04
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Argenx to EUR 700 from EUR 680 and keeps an Overweight rating on the shares.
H.C. Wainwright
Buy
maintain
$720 -> $774
2025-08-01
Reason
H.C. Wainwright
Price Target
$720 -> $774
2025-08-01
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Argenx to $774 from $720 and keeps a Buy rating on the shares. The company reported a "jaw-dropping" Q2, the analyst tells investors in a research note. The firm cites Vyvgart's "robust" sales performance for the target increase.
Baird
Joel Beatty
maintain
$680 -> $788
2025-08-01
Reason
Baird
Joel Beatty
Price Target
$680 -> $788
2025-08-01
maintain
Reason
Baird analyst Joel Beatty raised the firm's price target on Argenx to $788 from $680 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results which showed top line growth in all areas.
BofA
Buy
maintain
$829 -> $880
2025-08-01
Reason
BofA
Price Target
$829 -> $880
2025-08-01
maintain
Buy
Reason
BofA raised the firm's price target on Argenx to $880 from $829 and keeps a Buy rating on the shares. Gross-to-net concerns are "put to rest after a spectacular" Q2 report, argues the analyst, who is "highly encouraged" by the strong demand growth that the firm sees setting a new baseline for uptake in the near-term.
See All Ratings
Get winning stock picks in minutes
Valuation Metrics
The current forward P/E ratio for argenx SE (ARGX.O) is 33.01, compared to its 5-year average forward P/E of -77.29. For a more detailed relative valuation and DCF analysis to assess argenx SE 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-77.29
Current PE
33.01
Overvalued PE
137.96
Undervalued PE
-292.53
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-12.23
Current EV/EBITDA
26.26
Overvalued EV/EBITDA
88.88
Undervalued EV/EBITDA
-113.34
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
34.41
Current PS
8.57
Overvalued PS
63.35
Undervalued PS
5.46
Financials
Annual
Quarterly
FY2025Q2
YoY :
+98.60%
948.59M
Total Revenue
FY2025Q2
YoY :
-563.91%
203.84M
Operating Profit
FY2025Q2
YoY :
+744.14%
245.36M
Net Income after Tax
FY2025Q2
YoY :
+663.27%
3.74
EPS - Diluted
FY2025Q2
YoY :
-0.79%
88.33
Gross Profit Margin - %
FY2025Q2
YoY :
-211.39%
14.57
FCF Margin - %
FY2025Q2
YoY :
+324.79%
25.87
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
470.5K
Volume
5
6-9
Months
332.0K
Volume
5
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
4
164.7K
Volume
Months
6-9
6
118.6K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ARGX News & Events
Events Timeline
2025-07-31 (ET)
2025-07-31
05:55:06
Argenx reports Q2 EPS $3.74, consensus $3.05
2025-06-30 (ET)
2025-06-30
13:42:49
Argenx weakness presents 'attractive opportunity,' says BofA
2025-06-30
11:50:02
FDA flags possible safety signals in new report, says RBC Capital
Sign Up For More Events
Sign Up For More Events
News
7.5
08-12Newsfilterargenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis
7.0
08-09GlobenewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
7.0
08-05GlobenewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
Sign Up For More News
People Also Watch
HUBS
HubSpot Inc
423.780
USD
+0.71%
VALE
Vale SA
10.400
USD
+1.96%
IQV
IQVIA Holdings Inc
185.910
USD
+3.23%
SYY
Sysco Corp
80.750
USD
+1.10%
OWL
Blue Owl Capital Inc
20.320
USD
+2.89%
IR
Ingersoll Rand Inc
78.430
USD
+2.59%
OTIS
Otis Worldwide Corp
88.150
USD
+2.46%
EA
Electronic Arts Inc
177.910
USD
+1.02%
ACGL
Arch Capital Group Ltd
87.780
USD
-2.34%
WIT
Wipro Ltd
2.680
USD
+1.13%
FAQ
What is argenx SE (ARGX) stock price today?
The current price of ARGX is 637.56 USD — it has decreased -0.21 % in the last trading day.
What is argenx SE (ARGX)'s business?
What is the price predicton of ARGX Stock?
What is argenx SE (ARGX)'s revenue for the last quarter?
What is argenx SE (ARGX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for argenx SE (ARGX)'s fundamentals?
How many employees does argenx SE (ARGX). have?